BG103310A - Бензонафтиридини като бронхиални лечебни средства - Google Patents

Бензонафтиридини като бронхиални лечебни средства

Info

Publication number
BG103310A
BG103310A BG103310A BG10331099A BG103310A BG 103310 A BG103310 A BG 103310A BG 103310 A BG103310 A BG 103310A BG 10331099 A BG10331099 A BG 10331099A BG 103310 A BG103310 A BG 103310A
Authority
BG
Bulgaria
Prior art keywords
bronchial
benzonaphthyridins
therapeutical means
therapeutical
meanings
Prior art date
Application number
BG103310A
Other languages
English (en)
Other versions
BG63695B1 (bg
Inventor
Beate Gutterer
Hermann Amschler
Wolf-Ruediger Ulrich
Thomas Martin
Thomas Baer
Armin Hatzelmann
Karl Sanders
Rolf Beume
Hildegard Boss
Dietrich Haefner
Hans - Peter Kley
Karl-Josef Goebel
Dieter Flockerzi
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of BG103310A publication Critical patent/BG103310A/bg
Publication of BG63695B1 publication Critical patent/BG63695B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Съединенията са нови бронхиални лечебни средства.Те имат формула в която значенията на R1, R2, R3 и R4 са посочени в описанието.
BG103310A 1996-11-11 1999-04-05 Бензонафтиридини като бронхиални лечебни средства BG63695B1 (bg)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19646298 1996-11-11
EP96118188 1996-11-13
DE19739056 1997-09-05
PCT/EP1997/006096 WO1998021208A1 (en) 1996-11-11 1997-11-05 Benzonaphthyridines as bronchial therapeutics

Publications (2)

Publication Number Publication Date
BG103310A true BG103310A (bg) 2000-05-31
BG63695B1 BG63695B1 (bg) 2002-09-30

Family

ID=27216810

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103310A BG63695B1 (bg) 1996-11-11 1999-04-05 Бензонафтиридини като бронхиални лечебни средства

Country Status (31)

Country Link
US (1) US6008215A (bg)
EP (1) EP0937074B1 (bg)
JP (1) JP4223075B2 (bg)
KR (1) KR100484045B1 (bg)
CN (1) CN1090188C (bg)
AT (1) ATE234300T1 (bg)
AU (1) AU733129B2 (bg)
BG (1) BG63695B1 (bg)
BR (1) BR9713338B1 (bg)
CA (1) CA2270964C (bg)
CY (1) CY2476B1 (bg)
CZ (1) CZ288752B6 (bg)
DE (1) DE69719778T2 (bg)
DK (1) DK0937074T3 (bg)
EA (1) EA001551B1 (bg)
EE (1) EE03829B1 (bg)
ES (1) ES2195189T3 (bg)
GE (1) GEP20012390B (bg)
HK (1) HK1022151A1 (bg)
HU (1) HU226981B1 (bg)
ID (1) ID22042A (bg)
IL (1) IL129054A (bg)
NO (1) NO312764B1 (bg)
NZ (1) NZ334976A (bg)
PL (1) PL189641B1 (bg)
PT (1) PT937074E (bg)
RS (1) RS49607B (bg)
SI (1) SI0937074T1 (bg)
SK (1) SK283269B6 (bg)
TR (1) TR199900856T2 (bg)
WO (1) WO1998021208A1 (bg)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2195571T3 (es) 1998-05-05 2003-12-01 Altana Pharma Ag Nuevos benzonaftiridin-n-oxidos.
US6436952B1 (en) 1998-08-31 2002-08-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine-N-oxides comprising a PDE3 and PDE4 inhibiting activity
IT1303272B1 (it) 1998-10-29 2000-11-06 Zambon Spa Derivati triciclici inibitori della fosfodiesterasi 4
ATE356810T1 (de) * 1999-01-15 2007-04-15 Altana Pharma Ag Polysubstituted 6-phenylphenanthridines mit pde- iv hemmender wirkung
DK1147087T3 (da) 1999-01-15 2005-09-05 Altana Pharma Ag Phenanthridin-N-oxider med PDE-IV-inhiberende aktivitet
DK1147089T3 (da) * 1999-01-15 2006-04-10 Altana Pharma Ag Phenylphenanthridiner med PDE-IV-inhiberende virkning
CA2359449A1 (en) 1999-01-15 2000-07-20 Beate Gutterer Phenanthridine-n-oxides with pde-iv inhibiting activity
PT1212089E (pt) 1999-08-21 2006-08-31 Altana Pharma Ag Combinacao sinergica de roflumilast e salmeterol
NL1017973C2 (nl) * 2000-05-10 2002-11-08 Tristem Trading Cyprus Ltd Inrichting.
CA2438717C (en) * 2001-02-21 2011-08-30 Altana Pharma Ag 6-phenylbenzonaphthyridines
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
RS20050117A (en) * 2002-08-17 2007-06-04 Altana Pharma Ag., Novel benzonaphthyridines
EP1537109B1 (en) * 2002-09-04 2007-04-18 ALTANA Pharma AG Novel benzonaphthyridines
US7470704B2 (en) 2002-09-04 2008-12-30 Nycomed Gmbh Benzonaphthyridines
CN104817534A (zh) 2004-03-03 2015-08-05 塔科达有限责任公司 新的羟基-6-杂芳基菲啶及其作为pde4抑制剂的用途
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
US20070185149A1 (en) * 2004-03-10 2007-08-09 Altana Pharma Ag Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibtors
JP2007529471A (ja) * 2004-03-17 2007-10-25 アルタナ　ファルマ　アクチエンゲゼルシャフト 新規のｎ−（アルコキシアルキル）カルバモイル置換された６−フェニル−ベンゾナフチリジン誘導体及びｐｄｅ３／４インヒビターとしてのそれらの使用
ATE508130T1 (de) * 2004-09-08 2011-05-15 Nycomed Gmbh 3-oxa-10-aza-phenanthrene als pde4- oder pde3/4- inhibitoren
CA2579000C (en) 2004-09-08 2013-02-05 Altana Pharma Ag Novel 3-thia-10-aza-phenanthrene derivatives
WO2006092422A1 (en) * 2005-03-02 2006-09-08 Nycomed Gmbh Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
TW200808695A (en) * 2006-06-08 2008-02-16 Amgen Inc Benzamide derivatives and uses related thereto
JP5399905B2 (ja) * 2006-09-01 2014-01-29 センワ バイオサイエンシズ インコーポレイテッド セリン−トレオニンタンパク質キナーゼおよびｐａｒｐ調節因子
MX2010011288A (es) 2008-04-23 2010-11-09 Rigel Pharmaceuticals Inc Compuestos de carboxamida para el tratamiento de trastornos metabolicos.
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
CN108299429B (zh) * 2018-04-09 2021-10-08 中南大学 一类八氢苯并萘啶化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) * 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
EP0247971A3 (en) * 1986-05-29 1990-01-17 Sandoz Ag Novel pharmaceutical compositions comprising and use of cis-6-(4-acetanilido)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin
MY105344A (en) * 1990-05-16 1994-09-30 Byk Gulden Lomberg Chemische Fabrik New sulphonyl compounds

Also Published As

Publication number Publication date
CZ288752B6 (cs) 2001-08-15
NO992282D0 (no) 1999-05-11
US6008215A (en) 1999-12-28
ES2195189T3 (es) 2003-12-01
NO992282L (no) 1999-05-11
BG63695B1 (bg) 2002-09-30
EA199900421A1 (ru) 1999-10-28
AU733129B2 (en) 2001-05-10
HK1022151A1 (en) 2000-07-28
GEP20012390B (en) 2001-03-25
CA2270964A1 (en) 1998-05-22
JP2001503442A (ja) 2001-03-13
EP0937074A1 (en) 1999-08-25
DK0937074T3 (da) 2003-06-23
NZ334976A (en) 2000-10-27
CN1236367A (zh) 1999-11-24
CA2270964C (en) 2007-07-31
ID22042A (id) 1999-08-26
PL189641B1 (pl) 2005-09-30
KR20000053100A (ko) 2000-08-25
SI0937074T1 (en) 2003-08-31
EA001551B1 (ru) 2001-04-23
SK283269B6 (sk) 2003-04-01
YU19499A (sh) 2001-09-28
HU226981B1 (hu) 2010-04-28
CZ167599A3 (cs) 1999-11-17
HUP0000426A3 (en) 2001-04-28
CN1090188C (zh) 2002-09-04
WO1998021208A1 (en) 1998-05-22
RS49607B (sr) 2007-06-04
AU5317098A (en) 1998-06-03
TR199900856T2 (xx) 1999-07-21
KR100484045B1 (ko) 2005-04-20
BR9713338A (pt) 2000-05-09
BR9713338B1 (pt) 2009-12-01
ATE234300T1 (de) 2003-03-15
PT937074E (pt) 2003-07-31
SK62399A3 (en) 1999-10-08
EE03829B1 (et) 2002-08-15
DE69719778D1 (de) 2003-04-17
JP4223075B2 (ja) 2009-02-12
IL129054A0 (en) 2000-02-17
NO312764B1 (no) 2002-07-01
DE69719778T2 (de) 2004-02-05
EP0937074B1 (en) 2003-03-12
EE9900105A (et) 1999-10-15
CY2476B1 (en) 2005-05-03
IL129054A (en) 2002-07-25
PL333429A1 (en) 1999-12-06
HUP0000426A2 (hu) 2001-02-28

Similar Documents

Publication Publication Date Title
BG103310A (bg) Бензонафтиридини като бронхиални лечебни средства
BG103485A (bg) Кетобензамиди като инхибитори на калпаина
MX9700557A (es) Dihidrobenzofuranos.
CA2276455A1 (en) Phthalazinones
CA2297911A1 (en) Substituted 6-phenylphenanthridines
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
BG103251A (bg) Оксадиазоли, методи за получаването им и приложението им като лекарствени средства
ZA977240B (en) Novel benzamidines
BG103413A (bg) Производни на сулфиновата киселина, тяхното получаване и използване
MX9709240A (es) Fenilpiridazinonas.
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
BG101110A (bg) Заместени пиримидинови съединения и тяхното използване
AU2291097A (en) Novel phenanthridines substituted in the 6 position
PL345561A1 (en) Substituted benzoylcyclohexandiones
PL336640A1 (en) Substituted 3,3-diamino-2- propenonitriles, their production and application
TR199901386T2 (en) �midazopiridazinler.
GB2324091A (en) Metalloproteinase inhibitors
IN187760B (bg)
MX9700854A (es) Derivados de azabicicloheptano n-substituidos utiles como neurolepticos.
AU3300797A (en) Selenophene anti-tumor agents
PL343546A1 (en) Processes for preparing intermediates
ZA983231B (en) Substituted benzyloxyimino compounds.
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use
CY2582B2 (en) New imidazopyridines and oxazolopyridines
CA2195663A1 (en) Dihydrobenzofuranes